Anvisa aprova remédio de diabetes para o tratamento de doença renal

[{"selector":"#anim-4656ee3c-1107-4e30-ab85-91c46bcacfea","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-ec4b866e-f0c4-4bbd-8b9f-77b52c9ea754","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-31550579-de18-44ee-9e8f-6725136213a4","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-c6f9dbd5-d30e-4be1-bb13-34a4cd6ff8b5","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Racool_studio/Freepik

[{"selector":"#anim-1670e417-b9a7-4dbb-8885-fc1b1efaf3df","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-cbc2e176-e1b6-494a-b400-3ff359fbf890","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-088e72ab-ea30-45fe-b652-ce039aaa4caa","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-133ca3b6-4aa1-424e-a9f3-75ff51e6beaf","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] pikisuperstar/Freepik A Anvisa aprovou o uso da empagliflozina, remédio indicado para o tratamento da diabetes do tipo 2, para uma outra finalidade: o tratamento de doença renal crônica

[{"selector":"#anim-9dbc2eda-c38d-4ca4-9675-71b8eb0e1462","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b13cb7a5-d83c-4c43-8d72-0df072534d1b","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-3cb7e655-c867-4c65-95aa-028f05b0e7af","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-7c6d50b8-9fb9-443f-a697-810da958b6c8","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] stefamerpik/Freepik A aprovação foi baseada no estudo EMPA-KIDNEY, conduzido pela Unidade de Pesquisa em Saúde Populacional da Universidade de Oxford em parceria com as farmacêuticas Boehringer Ingelheim e Eli Lilly

[{"selector":"#anim-3494b507-1161-49b9-a2af-2785d2865d0b","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-a8553d0e-f11f-4a7e-8e92-40d01335fb9c","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-1508290f-da2b-4111-a5ca-c380f776d3a8","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-78948da3-9153-467d-a2c0-00f2d4b259cf","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] brgfx/Freepik O trabalho apontou que a molécula reduziu em 28% o risco de progressão da doença renal ou morte por problema cardiovascular em pacientes com doença renal crônica

[{"selector":"#anim-950e1d45-98ff-4d06-849c-ddb225a444d2","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-089486d5-6450-4d28-9e44-a40b666c7014","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-03966d17-0c2c-44ca-b547-201548a19818","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-52475ffd-a273-46ae-9496-f2dfcd0aed84","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Freepik Vale destacar que o medicamento já é utilizado em casos de insuficiência cardíaca

[{"selector":"#anim-12a7254e-4836-4b5c-a13e-5305aab1dea1","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-c71dfb3e-7c32-4693-91b9-ded545db61bf","keyframes":{"opacity":[0,1]},"delay":0,"duration":1500,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-849063c9-e586-4df3-844e-939921428f24","keyframes":{"opacity":[0,1]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"both"}] [{"selector":"#anim-fd7ddce0-b867-4f05-afe9-088a7f3c83de","keyframes":{"transform":["scale(0.3333333333333333)","scale(1)"]},"delay":0,"duration":500,"easing":"cubic-bezier(.3,0,.55,1)","fill":"forwards"}] Freepik Com a aprovação, agora é possível uma abordagem mais abrangente para tratar as condições cardiorrenais metabólicas

CNNBRASIL.COM.BR

[{"selector":"#anim-78cc2d59-5124-42a6-b770-d4636244b50a","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-14046ada-d8c7-4202-9d8a-415e644ce97f","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.4, 0.4, 0.0, 1)","fill":"both"}] [{"selector":"#anim-03f6f181-1805-46ef-b816-8f170e76c75c","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-8e66d421-bc97-4ad1-a9fd-b07e9cbc16f4","keyframes":{"transform":["translate3d(0px, 2132.63615%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-50830deb-b53a-4718-81a5-60d10622e225","keyframes":{"opacity":[0,1]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-0376f275-765b-4aa1-af2e-3ea0adc14047","keyframes":{"transform":["translate3d(-117.84387%, 0px, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":600,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-d518cd1e-79c1-4330-a4c2-2f1e8cae6c19","keyframes":{"opacity":[0,1]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] [{"selector":"#anim-b09dae2f-ea89-4c6c-b9a4-846eb6028f5b","keyframes":{"transform":["translate3d(0px, 1223.93157%, 0)","translate3d(0px, 0px, 0)"]},"delay":0,"duration":1000,"easing":"cubic-bezier(0.2, 0.6, 0.0, 1)","fill":"both"}] jcomp/Freepik leia mais em